N-Acetyl Semax Amidate
Also known as: NASA, Modified Semax, Enhanced Semax
An enhanced version of Semax with improved stability and potency for cognitive effects.
Overview
N-Acetyl Semax Amidate (NASA) is a modified form of Semax with an acetyl group on the N-terminus and an amide on the C-terminus. These modifications improve stability and potentially enhance potency and duration compared to standard Semax.
Mechanism of Action
Same as Semax (BDNF upregulation, NGF enhancement, dopamine/serotonin modulation) but with improved resistance to enzymatic degradation due to terminal modifications. May have enhanced CNS penetration.
Pharmacokinetics
Improved stability vs standard Semax. Intranasal administration. Potentially longer duration of action.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Cognitive Enhancement
100-300 mcg
1-2x daily
2-4 weeks
Lower doses than standard Semax
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Enhanced stability over standard Semax
- 2Potentially improved potency
- 3Same neurotrophic mechanisms
- 4Popular in nootropic community
Side Effects & Contraindications
Reported Side Effects
- Headache (rare)
- Nasal irritation
Contraindications
- Same as Semax
Safety Considerations
Research compound. Based on Semax safety profile. Limited formal safety data on modified version.
Storage Requirements
Refrigerate 2-8°C
Scientific References
- 1